Multiplexed Protein Quant.
How do you quantitate a number of proteins simultaneously, avoiding challenges of potential antibody cross-reactivity and variation in endogenous levels?
How do you avoid confounding protein interactions like soluble target and anti-drug antibodies, that plague traditional ligand-binding assays?
How do you implement your protein quant with sufficient throughput and with precise, reproducible results?
SISCAPA in the News
Nov 2014: Precision Antibody Awarded SBIR Contract to Develop High-Affinity, Anti-Peptide Antibodies for SISCAPA Assays
May 2014: SISCAPA Assay Technologies closes Series A round targeting wellness and chronic disease monitoring
April 2014: Serum thyroglobulin testing using SISCAPA technology and liquid chromatography tandem mass spectrometry now performed at Mayo Medical Laboratories
March 2014: SISCAPA Assay Tech Exploring Dried Blood Spot Sampling for Mail-in, Longitudinal Proteomic Testing